Inhibrx Biosciences, Inc. (INBX) has 9 SEC Form 4 insider filings on record in the last 90 days. That includes 3 insider purchases totalling $3.5M, and 2 sales totalling $279K. Most recent filing: Sept. 18, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 18, 2026 filed June 3, 2026 | FORSYTH DOUGLAS Director | $0 | 10,000 | 0% | No | |
|
|
||||||
| Sept. 18, 2026 filed June 3, 2026 | Vuori Kristiina MD Director | $0 | 10,000 | 0% | No | |
|
|
||||||
| Sept. 18, 2026 filed June 3, 2026 | MANHARD KIMBERLY Director | $0 | 10,000 | 0% | No | |
|
|
||||||
| Sept. 18, 2026 filed June 3, 2026 | Kayyem Jon Faiz Director | $0 | 10,000 | 0% | No | |
|
|
||||||
| Sept. 15, 2026 filed Sept. 11, 2026 | MANHARD KIMBERLY Director | −$163,543 | 1,500 | −17% | No | |
|
|
||||||
Showing the 5 most recent of 9 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free